 <h1>Ventolin Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>albuterol</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about albuterol. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Ventolin.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to albuterol: oral syrup, oral tablet, oral tablet extended release</i></p><p>Other dosage forms:</p><ul><li>inhalation aerosol powder, inhalation powder, inhalation solution, inhalation suspension</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, albuterol (the active ingredient contained in Ventolin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking albuterol:</p><p>
<i>More common</i>
</p><ul>
<li>Shakiness in the legs, arms, hands, or feet</li>
<li>trembling or shaking of the hands or feet</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Fast, irregular, pounding, or racing heartbeat or pulse</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Cough</li>
<li>difficulty breathing</li>
<li>difficulty with swallowing</li>
<li>hives or welts</li>
<li>hoarseness</li>
<li>large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
<li>noisy breathing</li>
<li>redness of the skin</li>
<li>shortness of breath</li>
<li>skin rash</li>
<li>slow or irregular breathing</li>
<li>swelling of the mouth or throat</li>
<li>tightness in the chest</li>
<li>wheezing</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>anxiety</li>
<li>arm, back, or jaw pain</li>
<li>blurred vision</li>
<li>chest pain or discomfort</li>
<li>confusion</li>
<li>convulsions</li>
<li>extra heartbeats</li>
<li>fainting</li>
<li>hallucinations</li>
<li>headache</li>
<li>irritability</li>
<li>lightheadedness</li>
<li>mood or mental changes</li>
<li>muscle pain or cramps</li>
<li>muscle spasm or jerking of all extremities</li>
<li>nervousness</li>
<li>nightmares</li>
<li>pounding in the ears</li>
<li>restlessness</li>
<li>sudden loss of consciousness</li>
<li>sweating</li>
<li>total body jerking</li>
<li>unusual feeling of excitement</li>
<li>vomiting</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of albuterol may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Dizziness</li>
<li>feeling of warmth</li>
<li>irritability</li>
<li>nausea</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>sleeplessness</li>
<li>trouble with holding or releasing urine</li>
<li>trouble sleeping</li>
<li>unable to sleep</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Sleepiness</li>
<li>unusual drowsiness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bad, unusual, or unpleasant (after) taste</li>
<li>change in taste</li>
<li>feeling of constant movement of self or surroundings</li>
<li>gagging</li>
<li>rough, scratchy sound to voice</li>
<li>sensation of spinning</li>
<li>tightness in the throat</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to albuterol: compounding powder, inhalation aerosol, inhalation aerosol with adapter, inhalation capsule, inhalation powder, inhalation solution, oral syrup, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most commonly reported adverse reactions are: Taste alteration (bad, unpleasant and unusual taste), mouth and throat irritation, fine tremor (usually of the hands), nausea, sweating, restlessness, headache and dizziness.  These undesirable effects may subside on continuation of treatment.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Peripheral vasodilation, increase in heart rate </p>
<p><b>Common</b> (1% to 10%): Palpitations, tachycardia, pallor</p>
<p><b>Rare</b> (0.01% to 0.1%): Myocardial ischemia, arrhythmias (including atrial fibrillation, supraventricular tachycardia, extra systoles)</p>
<p><b>Very rare</b> (less than 0.01%): Cardiovascular collapse, thrombopenia</p>
<p><b>Frequency not reported</b>: Angina, hypertension, hypotension, flushing<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 18.8%), tremor (up to 24.2%), excitement (up to 20%), nervousness (up to 15%)</p>
<p><b>Common</b> (1% to 10%): Migraine, dizziness, shakiness, hyperkinesia, emotional lability</p>
<p><b>Uncommon</b> (0.1% to 1%): Somnolence, dizziness, drowsiness, restlessness, irritability</p>
<p><b>Frequency not reported</b>: Central nervous system stimulation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Skin/Appendage Infection (1.7%), pruritus, rash, erythema, urticaria, angioedema, sweating<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastroenteritis, nausea, oropharyngeal pain, vomiting, increased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Epigastric pain, stomach ache, loss of appetite</p>
<p><b>Rare</b> (less than 0.1%): Sore mouth</p>
<p><b>Frequency not reported</b>: Oropharyngeal edema, throat irritation, altered taste, glossitis, tongue ulceration, gagging, drying or irritation of the oropharynx<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Rare</b> (less than 0.1%): Nephritis</p>
<p><b>Frequency not reported</b>: Difficulty in micturition<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic reaction</p>
<p><b>Very rare</b> (less than 0.01%): angioedema, urticaria, bronchospasm, hypotension and collapse<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Lymphadenopathy<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Application site reaction (mouth and throat irritation, burning sensation of the tongue)</p>
<p><b>Frequency not reported</b>: Slight pain or stinging (IM injection)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, muscles cramps</p>
<p><b>Uncommon</b> (0.1% to 1%): Myalgia</p>
<p><b>Very rare</b> (less than 0.01%): Fine tremor (particularly of hands)</p>
<p><b>Frequency not reported</b>: Myoclonus<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Cold symptoms, flue syndrome, pain, pyrexia, hyperactivity, excitement</p>
<p><b>Uncommon</b> (0.1% to 1%): Epistaxis, fatigue, otitis media,</p>
<p><b>Frequency not reported</b>: Weakness<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Tenseness</p>
<p><b>Uncommon</b> (0.1% to 1%): Sleepiness, sleep disturbance</p>
<p><b>Rare</b> (0.01% to 0.1%): Hallucinations</p>
<p><b>Very rare</b> (less than 0.01%): Insomnia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Asthma exacerbation (13%), chest pain, bronchitis, sinus headache, upper respiratory infection, nasopharyngitis, sinusitis, bronchitis, cough </p>
<p><b>Very rare</b> (less than 0.01%): Paradoxical bronchospasm, bronchospasm</p>
<p><b>Frequency not reported</b>: Aggravated bronchospasm, asthma exacerbation, chest discomfort, pulmonary edema<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Dilated pupils, conjunctivitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Hypokalemia, hyperglycemia, increase of insulin, free fatty acids, glycerol and ketone bodies</p>
<p><b>Postmarketing reports</b>: Metabolic acidosis, lactic acidosis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Albuterol (albuterol (salbutamol))." Physicians Total Care, Tulsa, OK. </p><p id="ref_2">2. "Product Information. Albuterol Extended Release (albuterol (salbutamol))." Dava Pharmaceuticals Inc, Fort Lee, NJ. </p><p id="ref_3">3. Price AH, Clissold SP "Salbutamol in the 1980s. A reappraisal of its clinical efficacy." Drugs 38 (1989): 77-122</p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_5">5. "Product Information. Albuterol Sulfate (albuterol (salbutamol))." Vista Pharm Inc, Birmingham, AL. </p><p id="ref_6">6. "Albuterol." Med Lett Drugs Ther 23 (1981): 81-2</p><p id="ref_7">7. Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9</p><p id="ref_8">8. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_9">9. Meyer MF,  Hopkins WE,  Kaminsky DA "Cardiovascular collapse in a 77-year-old-woman with an asthma exacerbation following bronchodilator treatment." Chest 124 (2003): 1160-3</p><p id="ref_10">10. Vathenen AS, Britton JR, Ebden P, Cookson JB, Wharrad HJ, Tattersfield AE "High-dose inhaled albuterol in severe chronic airflow limitation." Am Rev Respir Dis 138 (1988): 850-5</p><p id="ref_11">11. Breeden CC, Safirstein BH "Albuterol and spacer-induced atrial fibrillation." Chest 98 (1990): 762-3</p><p id="ref_12">12. Davies AE, Robertson MJ "Pulmonary oedema after the administration of intravenous salbutamol and ergometrine. Case report." Br J Obstet Gynaecol 87 (1980): 539-41</p><p id="ref_13">13. Kallergis EM,  Manios EG,  Kanoupakis EM, et al. "Acute electrophysiologic effects of inhaled salbutamol in humans." Chest 127 (2005): 2057-63</p><p id="ref_14">14. Neville E, Corris PA, Vivian J, Nariman S, Gibson GJ "Nebulised salbutamol and angina." Br Med J (Clin Res Ed) 285 (1982): 796-7</p><p id="ref_15">15. Hawker F "Five cases of pulmonary oedema associated with beta 2-sympathomimetic treatment of premature labour." Anaesth Intensive Care 12 (1984): 159-62</p><p id="ref_16">16. Shovlin CL, Tam FW "Salbutamol nebuliser and precipitation of critical cardiac ischaemia." Lancet 336 (1990): 1258</p><p id="ref_17">17. Mettauer B, Rouleau JL, Burgess JH "Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure." Am Heart J 109 (1985): 840-7</p><p id="ref_18">18. Finch JS "Cardiovascular toxicity: clinical evaluation of albuterol, isoproterenol and placebo in rising dose tolerance trial." Ann Allergy 47 (1981): 402-4</p><p id="ref_19">19. Lipworth BJ, Struthers AD, McDevitt DG "Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics." Am Rev Respir Dis 140 (1989): 586-92</p><p id="ref_20">20. Godfrey S "Worldwide experience with albuterol (salbutamol)." Ann Allergy 47 (1981): 423-6</p><p id="ref_21">21. Chazan R, Droszcz W, Maruchin JE "Pharmacodynamics of salbutamol in humans." Int J Clin Pharmacol Ther Toxicol 26 (1988): 385-7</p><p id="ref_22">22. Tan SN "Peri-partum pulmonary oedema." Anaesth Intensive Care 19 (1991): 111-3</p><p id="ref_23">23. Larsson S "Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration." Acta Med Scand Suppl 608 (1977): 1-40</p><p id="ref_24">24. Jenne JW "Can oral beta(2) agonists cause heart failure?" Lancet 352 (1998): 1081-2</p><p id="ref_25">25. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9</p><p id="ref_26">26. Lisi DM "Muscle spasms and creatine phosphokinase elevation following salbutamol administration." Eur Respir J 2 (1989): 98</p><p id="ref_27">27. Craig TJ, Smits W, Soontornniyomkiu V "Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol." Ann Allergy Asthma Immunol 77 (1996): 488-90</p><p id="ref_28">28. Svedmyr N, Lofdahl CG "The use of beta(2)-adrenoceptor agonists in the treatment of bronchial asthma." Pharmacol Toxicol 78 (1996): 3-11</p><p id="ref_29">29. Sears MR, Taylor DR, Print CG, et al. "Regular inhaled beta-agonist treatment in bronchial asthma." Lancet 336 (1990): 1391-5</p><p id="ref_30">30. Cockcroft DW, Swystun VA "Functional antagonism: tolerance produced by inhaled beta(2) agonists." Thorax 51 (1996): 1051-6</p><p id="ref_31">31. van Schayck CP, Dompeling E, van Herwaarden CL, et al. "Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study." BMJ 303 (1991): 1426-31</p><p id="ref_32">32. Yates DH, Kharitonov SA, Barnes PJ "An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta(2)-agonist." Am J Respir Crit Care Med 154 (1996): 1603-7</p><p id="ref_33">33. Drazen JM, Israel E, Boushey HA, et al. "Comparisons of regularly scheduled with as-needed use of albuterol in mild asthma." N Engl J Med 335 (1996): 841-7</p><p id="ref_34">34. Whitehouse AM, Novosel S "Salbutamol psychosis." Biol Psychiatry 26 (1989): 631-3</p><p id="ref_35">35. Hall RC, Beresford TP, Stickney SK, Nasdahl CS, Coleman JH "Psychiatric reactions produced by respiratory drugs." Psychosomatics 26 (1985): 605-8,616-7</p><p id="ref_36">36. Ray I, Evans CJ "Paranoid psychosis with Ventolin (salbutamol tablets b.p.)." Can Psychiatr Assoc J 23 (1978): 427</p><p id="ref_37">37. Martin W, Unutzer J, Szuba MP "Exacerbation of psychosis associated with inhaled albuterol." J Clin Psychopharmacol 15 (1995): 446-7</p><p id="ref_38">38. Raghunathan K,  Nagajothi N "Paradoxical bronchospasm: a potentially life threatening adverse effect of albuterol." South Med J 99 (2006): 288-9</p><p id="ref_39">39. Stratakos G,  Kalomenidis J,  Routsi C,  Papiris S,  Roussos C "Transient lactic acidosis as a side effect of inhaled salbutamol." Chest 122 (2002): 385-6</p><p id="ref_40">40. Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20</p><p id="ref_41">41. Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9</p><p id="ref_42">42. Montoliu J, Almirall J, Ponz E, Campistol JM, Revert L "Treatment of hyperkalaemia in renal failure with salbutamol inhalation." J Intern Med 228 (1990): 35-7</p><p id="ref_43">43. Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71</p><p id="ref_44">44. Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7</p><p id="ref_45">45. Liem EB,  Mnookin SC,  Mahla ME "Albuterol-induced Lactic Acidosis." Anesthesiology 99 (2003): 505-506</p><p id="ref_46">46. "Hypokalaemia due to salbutamol overdosage." Br Med J (Clin Res Ed) 283 (1981): 500-1</p><p id="ref_47">47. Allon M, Dunlay R, Copkney C "Nebulized albuterol for acute hyperkalemia in patients on hemodialysis." Ann Intern Med 110 (1989): 426-9</p><p id="ref_48">48. Habib GS,  Saliba WR,  Cohen L "Diabetic ketoacidosis associated with oral salbutamol overdose." Am J Med 113 (2002): 701-2</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Does either Ventolin or albuterol contain steroids?</li>
<li>Does coffee help with asthma?</li>
<li>Can you use an expired inhaler?</li>
<li>What is albuterol sulfate and can I take it if I'm allergic to sulfa?</li>
<li>How do you use the ProAir Digihaler?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Ventolin (albuterol)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>26 Reviews</li>
<li>Drug class: adrenergic bronchodilators</li>
<li>FDA Alerts (5)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
<li>Ventolin Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Ventolin Rotacaps &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>ProAir HFA, Proventil, Proventil HFA, ProAir RespiClick, ... +4 more</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Ventolin HFA</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Asthma, acute</li>
<li>Bronchiectasis</li>
<li>COPD, Acute</li>
<li>Asthma, Maintenance</li>
<li>COPD, Maintenance</li>
<li>Bronchospasm Prophylaxis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to albuterol: compounding powder, inhalation aerosol, inhalation aerosol with adapter, inhalation capsule, inhalation powder, inhalation solution, oral syrup, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The most commonly reported adverse reactions are: Taste alteration (bad, unpleasant and unusual taste), mouth and throat irritation, fine tremor (usually of the hands), nausea, sweating, restlessness, headache and dizziness.  These undesirable effects may subside on continuation of treatment.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Peripheral vasodilation, increase in heart rate </p><p><b>Common</b> (1% to 10%): Palpitations, tachycardia, pallor</p><p><b>Rare</b> (0.01% to 0.1%): Myocardial ischemia, arrhythmias (including atrial fibrillation, supraventricular tachycardia, extra systoles)</p><p><b>Very rare</b> (less than 0.01%): Cardiovascular collapse, thrombopenia</p><p><b>Frequency not reported</b>: Angina, hypertension, hypotension, flushing<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 18.8%), tremor (up to 24.2%), excitement (up to 20%), nervousness (up to 15%)</p><p><b>Common</b> (1% to 10%): Migraine, dizziness, shakiness, hyperkinesia, emotional lability</p><p><b>Uncommon</b> (0.1% to 1%): Somnolence, dizziness, drowsiness, restlessness, irritability</p><p><b>Frequency not reported</b>: Central nervous system stimulation<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Skin/Appendage Infection (1.7%), pruritus, rash, erythema, urticaria, angioedema, sweating<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Gastroenteritis, nausea, oropharyngeal pain, vomiting, increased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Epigastric pain, stomach ache, loss of appetite</p><p><b>Rare</b> (less than 0.1%): Sore mouth</p><p><b>Frequency not reported</b>: Oropharyngeal edema, throat irritation, altered taste, glossitis, tongue ulceration, gagging, drying or irritation of the oropharynx<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Rare</b> (less than 0.1%): Nephritis</p><p><b>Frequency not reported</b>: Difficulty in micturition<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Allergic reaction</p><p><b>Very rare</b> (less than 0.01%): angioedema, urticaria, bronchospasm, hypotension and collapse<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Lymphadenopathy<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Application site reaction (mouth and throat irritation, burning sensation of the tongue)</p><p><b>Frequency not reported</b>: Slight pain or stinging (IM injection)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, muscles cramps</p><p><b>Uncommon</b> (0.1% to 1%): Myalgia</p><p><b>Very rare</b> (less than 0.01%): Fine tremor (particularly of hands)</p><p><b>Frequency not reported</b>: Myoclonus<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Cold symptoms, flue syndrome, pain, pyrexia, hyperactivity, excitement</p><p><b>Uncommon</b> (0.1% to 1%): Epistaxis, fatigue, otitis media,</p><p><b>Frequency not reported</b>: Weakness<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Tenseness</p><p><b>Uncommon</b> (0.1% to 1%): Sleepiness, sleep disturbance</p><p><b>Rare</b> (0.01% to 0.1%): Hallucinations</p><p><b>Very rare</b> (less than 0.01%): Insomnia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Asthma exacerbation (13%), chest pain, bronchitis, sinus headache, upper respiratory infection, nasopharyngitis, sinusitis, bronchitis, cough </p><p><b>Very rare</b> (less than 0.01%): Paradoxical bronchospasm, bronchospasm</p><p><b>Frequency not reported</b>: Aggravated bronchospasm, asthma exacerbation, chest discomfort, pulmonary edema<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Dilated pupils, conjunctivitis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (less than 0.1%): Hypokalemia, hyperglycemia, increase of insulin, free fatty acids, glycerol and ketone bodies</p><p><b>Postmarketing reports</b>: Metabolic acidosis, lactic acidosis<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Albuterol (albuterol (salbutamol))." Physicians Total Care, Tulsa, OK. </p><p id="ref_2">2. "Product Information. Albuterol Extended Release (albuterol (salbutamol))." Dava Pharmaceuticals Inc, Fort Lee, NJ. </p><p id="ref_3">3. Price AH, Clissold SP "Salbutamol in the 1980s. A reappraisal of its clinical efficacy." Drugs 38 (1989): 77-122</p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_5">5. "Product Information. Albuterol Sulfate (albuterol (salbutamol))." Vista Pharm Inc, Birmingham, AL. </p><p id="ref_6">6. "Albuterol." Med Lett Drugs Ther 23 (1981): 81-2</p><p id="ref_7">7. Larsson S, Svedmyr N "Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol inasthmatics." Am Rev Respir Dis 116 (1977): 861-9</p><p id="ref_8">8. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_9">9. Meyer MF,  Hopkins WE,  Kaminsky DA "Cardiovascular collapse in a 77-year-old-woman with an asthma exacerbation following bronchodilator treatment." Chest 124 (2003): 1160-3</p><p id="ref_10">10. Vathenen AS, Britton JR, Ebden P, Cookson JB, Wharrad HJ, Tattersfield AE "High-dose inhaled albuterol in severe chronic airflow limitation." Am Rev Respir Dis 138 (1988): 850-5</p><p id="ref_11">11. Breeden CC, Safirstein BH "Albuterol and spacer-induced atrial fibrillation." Chest 98 (1990): 762-3</p><p id="ref_12">12. Davies AE, Robertson MJ "Pulmonary oedema after the administration of intravenous salbutamol and ergometrine. Case report." Br J Obstet Gynaecol 87 (1980): 539-41</p><p id="ref_13">13. Kallergis EM,  Manios EG,  Kanoupakis EM, et al. "Acute electrophysiologic effects of inhaled salbutamol in humans." Chest 127 (2005): 2057-63</p><p id="ref_14">14. Neville E, Corris PA, Vivian J, Nariman S, Gibson GJ "Nebulised salbutamol and angina." Br Med J (Clin Res Ed) 285 (1982): 796-7</p><p id="ref_15">15. Hawker F "Five cases of pulmonary oedema associated with beta 2-sympathomimetic treatment of premature labour." Anaesth Intensive Care 12 (1984): 159-62</p><p id="ref_16">16. Shovlin CL, Tam FW "Salbutamol nebuliser and precipitation of critical cardiac ischaemia." Lancet 336 (1990): 1258</p><p id="ref_17">17. Mettauer B, Rouleau JL, Burgess JH "Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure." Am Heart J 109 (1985): 840-7</p><p id="ref_18">18. Finch JS "Cardiovascular toxicity: clinical evaluation of albuterol, isoproterenol and placebo in rising dose tolerance trial." Ann Allergy 47 (1981): 402-4</p><p id="ref_19">19. Lipworth BJ, Struthers AD, McDevitt DG "Tachyphylaxis to systemic but not to airway responses during prolonged therapy with high dose inhaled salbutamol in asthmatics." Am Rev Respir Dis 140 (1989): 586-92</p><p id="ref_20">20. Godfrey S "Worldwide experience with albuterol (salbutamol)." Ann Allergy 47 (1981): 423-6</p><p id="ref_21">21. Chazan R, Droszcz W, Maruchin JE "Pharmacodynamics of salbutamol in humans." Int J Clin Pharmacol Ther Toxicol 26 (1988): 385-7</p><p id="ref_22">22. Tan SN "Peri-partum pulmonary oedema." Anaesth Intensive Care 19 (1991): 111-3</p><p id="ref_23">23. Larsson S "Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration." Acta Med Scand Suppl 608 (1977): 1-40</p><p id="ref_24">24. Jenne JW "Can oral beta(2) agonists cause heart failure?" Lancet 352 (1998): 1081-2</p><p id="ref_25">25. Wong CS, Pavord ID, Williams J, Britton JR, Tattersfield AE "Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma." Lancet 336 (1990): 1396-9</p><p id="ref_26">26. Lisi DM "Muscle spasms and creatine phosphokinase elevation following salbutamol administration." Eur Respir J 2 (1989): 98</p><p id="ref_27">27. Craig TJ, Smits W, Soontornniyomkiu V "Elevation of creatine kinase from skeletal muscle associated with inhaled albuterol." Ann Allergy Asthma Immunol 77 (1996): 488-90</p><p id="ref_28">28. Svedmyr N, Lofdahl CG "The use of beta(2)-adrenoceptor agonists in the treatment of bronchial asthma." Pharmacol Toxicol 78 (1996): 3-11</p><p id="ref_29">29. Sears MR, Taylor DR, Print CG, et al. "Regular inhaled beta-agonist treatment in bronchial asthma." Lancet 336 (1990): 1391-5</p><p id="ref_30">30. Cockcroft DW, Swystun VA "Functional antagonism: tolerance produced by inhaled beta(2) agonists." Thorax 51 (1996): 1051-6</p><p id="ref_31">31. van Schayck CP, Dompeling E, van Herwaarden CL, et al. "Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study." BMJ 303 (1991): 1426-31</p><p id="ref_32">32. Yates DH, Kharitonov SA, Barnes PJ "An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta(2)-agonist." Am J Respir Crit Care Med 154 (1996): 1603-7</p><p id="ref_33">33. Drazen JM, Israel E, Boushey HA, et al. "Comparisons of regularly scheduled with as-needed use of albuterol in mild asthma." N Engl J Med 335 (1996): 841-7</p><p id="ref_34">34. Whitehouse AM, Novosel S "Salbutamol psychosis." Biol Psychiatry 26 (1989): 631-3</p><p id="ref_35">35. Hall RC, Beresford TP, Stickney SK, Nasdahl CS, Coleman JH "Psychiatric reactions produced by respiratory drugs." Psychosomatics 26 (1985): 605-8,616-7</p><p id="ref_36">36. Ray I, Evans CJ "Paranoid psychosis with Ventolin (salbutamol tablets b.p.)." Can Psychiatr Assoc J 23 (1978): 427</p><p id="ref_37">37. Martin W, Unutzer J, Szuba MP "Exacerbation of psychosis associated with inhaled albuterol." J Clin Psychopharmacol 15 (1995): 446-7</p><p id="ref_38">38. Raghunathan K,  Nagajothi N "Paradoxical bronchospasm: a potentially life threatening adverse effect of albuterol." South Med J 99 (2006): 288-9</p><p id="ref_39">39. Stratakos G,  Kalomenidis J,  Routsi C,  Papiris S,  Roussos C "Transient lactic acidosis as a side effect of inhaled salbutamol." Chest 122 (2002): 385-6</p><p id="ref_40">40. Kantola I, Tarssanen L "Hypokalemia from usual salbutamol dosage ." Chest 89 (1986): 619-20</p><p id="ref_41">41. Hastwell G, Lambert BE "The effect of oral salbutamol on serum potassium and blood sugar." Br J Obstet Gynaecol 85 (1978): 767-9</p><p id="ref_42">42. Montoliu J, Almirall J, Ponz E, Campistol JM, Revert L "Treatment of hyperkalaemia in renal failure with salbutamol inhalation." J Intern Med 228 (1990): 35-7</p><p id="ref_43">43. Whyte KF, Addis GJ, Whitesmith R, Reid JL "The mechanism of salbutamol-induced hypokalaemia." Br J Clin Pharmacol 23 (1987): 65-71</p><p id="ref_44">44. Rakhmanina NY, Kearns GL, Farrar HC "Hypokalemia in an asthmatic child from abuse of albuterol metered dose inhaler." Pediatr Emerg Care 14 (1998): 145-7</p><p id="ref_45">45. Liem EB,  Mnookin SC,  Mahla ME "Albuterol-induced Lactic Acidosis." Anesthesiology 99 (2003): 505-506</p><p id="ref_46">46. "Hypokalaemia due to salbutamol overdosage." Br Med J (Clin Res Ed) 283 (1981): 500-1</p><p id="ref_47">47. Allon M, Dunlay R, Copkney C "Nebulized albuterol for acute hyperkalemia in patients on hemodialysis." Ann Intern Med 110 (1989): 426-9</p><p id="ref_48">48. Habib GS,  Saliba WR,  Cohen L "Diabetic ketoacidosis associated with oral salbutamol overdose." Am J Med 113 (2002): 701-2</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Does either Ventolin or albuterol contain steroids?</li>
<li>Does coffee help with asthma?</li>
<li>Can you use an expired inhaler?</li>
<li>What is albuterol sulfate and can I take it if I'm allergic to sulfa?</li>
<li>How do you use the ProAir Digihaler?</li>
</ul><h2>More about Ventolin (albuterol)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>26 Reviews</li>
<li>Drug class: adrenergic bronchodilators</li>
<li>FDA Alerts (5)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
<li>Ventolin Inhalation &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
<li>Ventolin Rotacaps &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Ventolin HFA</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Asthma, acute</li>
<li>Bronchiectasis</li>
<li>COPD, Acute</li>
<li>Asthma, Maintenance</li>
<li>COPD, Maintenance</li>
<li>Bronchospasm Prophylaxis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>